Regional Account Manager-Neurology (Michigan based Candidates)
Axsome Therapeutics IncSalary not specified
- Full Time
- Junior (1 to 2 years)
Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Biotechnology, HealthcareIndustries
Requirements
Candidates must possess a Bachelor’s degree and a minimum of 10 years of experience in pharmaceutical or biotech account strategy and account management, with a strong preference for prior experience in the vaccine industry. Knowledge and understanding of product reimbursement is also preferred.
Responsibilities
The Regional Account Manager will develop and execute strategic account plans to enhance customer relationships, achieve sales targets, and facilitate retention and growth within key accounts such as Regional Health Systems, State Awardees/VFC, Federally Qualified Health Centers, Contracting Entities, Physician Groups, and Specialty Providers. They will act as the primary point of contact for Moderna, analyze sales trends, build long-term relationships, collaborate with internal teams, represent Moderna at industry events, and ensure successful communication and negotiation with customers while adhering to company values.
Skills
Account Management
Sales
Negotiation
Customer Relationship Management
Strategic Planning
Communication
Business Development
mRNA
Vaccination
Moderna
Develops mRNA-based medicines for health
About Moderna
Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.
Key Metrics
Cambridge, MassachusettsHeadquarters
2010Year Founded
$5,925.5MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
5,001-10,000Employees